Cargando…
The effect of anti-dementia drugs on Alzheimer disease-induced cognitive impairment: A network meta-analysis
BACKGROUND: Cognitive impairment is a principal manifestation of Alzheimer disease (AD). To provide a clinical reference for the treatment of AD, a network meta-analysis (NMA) was performed to evaluate the effects of different anti-dementia drugs on the cognitive impairment exhibited by patients wit...
Autores principales: | Cui, Cui-Cui, Sun, Yong, Wang, Xin-Yi, Zhang, Yuan, Xing, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6635177/ https://www.ncbi.nlm.nih.gov/pubmed/31277107 http://dx.doi.org/10.1097/MD.0000000000016091 |
Ejemplares similares
-
Cognitive Blackouts in Mild Cognitive Impairment and Alzheimer's Dementia
por: Adler, Georg, et al.
Publicado: (2018) -
Anti-Dementia Drugs for Psychopathology and Cognitive Impairment in Schizophrenia: A Systematic Review and Meta-Analysis
por: Kishi, Taro, et al.
Publicado: (2018) -
Associations of Antihypertensive Medication Consumption and Drug-Drug Interaction with Statin and Metformin with Reduced Alzheimer's Disease and Related Dementias Risk among Hypertensive Patients with Mild Cognitive Impairment using High Volume Claims Data
por: Lundin, Sori K., et al.
Publicado: (2023) -
The association of antidepressant drug usage with cognitive impairment or dementia, including Alzheimer disease: A systematic review and meta‐analysis
por: Moraros, John, et al.
Publicado: (2016) -
Aberrant intra- and inter-network connectivity architectures in Alzheimer’s disease and mild cognitive impairment
por: Wang, Pan, et al.
Publicado: (2015)